Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Chromatography of recombinant proteins.

J V O'Connor1

  • 1Genentech, Inc., South San Francisco, CA 94080, USA.

Developments in Biological Standardization
|August 27, 1999
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

The diagnosis and treatment of non-cardiac thoracic trauma.

Journal of the Royal Army Medical Corps·2010
Same author

Incidence of infection and premature crimp failure after repair of cranial cruciate ligament-deficient stifles in 110 dogs.

The Veterinary record·2007
Same author

Computational and experimental models of the human torso for non-penetrating ballistic impact.

Journal of biomechanics·2005
Same author

A report of the treatment of coronary artery aneurysm without cardiopulmonary bypass.

The heart surgery forum·2001
Same author

Preparation, isolation, and characterization of cutin monomers and oligomers from tomato peels.

Journal of agricultural and food chemistry·1999
Same author

A convenient microscale colorimetric method for terminal galactose on immunoglobulins.

Biochemical and biophysical research communications·1999

Reversed-phase high-performance liquid chromatography (rpHPLC) and affinity chromatography effectively separate protein variants. These methods are crucial for ensuring the quality and biological activity of therapeutic proteins like recombinant human insulin-like growth factor I (rhlGF-I).

Area of Science:

  • Biochemistry
  • Analytical Chemistry
  • Protein Science

Background:

  • Therapeutic protein variants can impact efficacy and safety.
  • Robust analytical methods are needed to characterize these variants.
  • Ensuring protein quality is critical for biopharmaceutical development.

Purpose of the Study:

  • To demonstrate the utility of rpHPLC and affinity chromatography for separating protein variants.
  • To highlight the importance of variant characterization for therapeutic protein quality control.
  • To establish a link between variant identification and biological activity assessment.

Main Methods:

  • Reversed-phase high-performance liquid chromatography (rpHPLC) for variant separation.
  • Affinity chromatography for resolving specific protein variants.

Related Experiment Videos

  • Analysis of recombinant human insulin-like growth factor I (rhlGF-I) and recombinant human deoxyribonuclease (rhDNase).

    • Main Results:

    • rpHPLC successfully separated rhlGF-I variants, including racemized serine and methionine sulfoxide.
    • Affinity chromatography resolved rhDNase variants based on amino acid substitutions.
    • rpHPLC rapidly detected O-linked sugars on recombinant human thrombopoietin.

    Conclusions:

    • rpHPLC and affinity chromatography are powerful tools for characterizing protein variants.
    • Variant control through analytical methods is essential for therapeutic protein manufacturing.
    • Correlating variants with biological activity ensures safe and effective protein therapeutics.